State of the art analytical comparability: A review

Developments in Biologicals

Volumn 122, Issue , 2005, Pages 3-26

  Chirino, A J ^a,c   Mire Sluis, A R ^b  

^a Xencor Inc   (United States)

^b Center for Drug Evaluation and Research   (United States)

^c CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; RECOMBINANT PROTEIN;

BIOASSAY; CHEMISTRY; CONFERENCE PAPER; HUMAN; METHODOLOGY; ORGANIZATION; STANDARD;

BIOLOGICAL ASSAY; CONGRESSES; HUMANS; PHARMACEUTICAL PREPARATIONS; RECOMBINANT PROTEINS;

EID: 33644626353     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (80)

1. Johnson IS: The trials and tribulations of producing the first genetically engineered drug. Nat Rev Drug Discov 2003;2(9):747-751.
2. Luo P, Hayes RJ, Chan C, Stark DM, Hwang MY, Jacinto JM, Juvvadi P, Chung HS, Kundu A, Ary ML, Dahiyat BI: Development of a cytokine analog with enhanced stability using computational ultrahigh throughput screening. Protein Sci 2002;11(5):1218-1226.
3. Moorhouse KG, Nashabeh W, Deveney J, Bjork NS, Mulkerrin MG, Ryskamp T: Validation of an HPLC method for the analysis of the charge heterogeneity of the recombinant monoclonal antibody IDEC-C2B8 after papain digestion. J Pharm Biomed Anal 1997;16(4):593-603.
4. Gitlin G, Tsarbopoulos A, Patel ST, Sydor W, Pramanik BN, Jacobs S, Westreich L, Mittelman S, Bausch JN: Isolation and characterization of a monomethioninesulfoxide variant of interferon alpha-2b. Pharm Res 1996;13(5):762-769.
5. Paranandi MV, Guzzetta AW, Hancock WS, Aswad DW: Deamidation and isoaspartate formation during in vitro aging of recombinant tissue plasminogen activator. J Biol Chem 1994;269(1):243-253.
6. Renlund S, Klintrot IM, Nunn M, Schrimsher JL, Wernstedt C, Hellman U: Peptide mapping on HIV polypeptides expressed in Escherichia coli. Quality control of different batches and identification of tryptic fragments containing residues of aromatic amino acids or cysteine. J Chromatogr 1990;512:325-335.
7. Zhang W, Czupryn JM, Boyle PT Jr, Amari J: Characterization of asparagine deamidation and aspartate isomerization in recombinant human interleukin-11. Pharm Res 2002;19(8):1223-1231.
8. Harris RJ, Murnane AA, Utter SL, Wagner KL, Cox ET, Polastri GD, Helder JC, Sliwkowski MB: Assessing genetic heterogeneity in production cell lines: detection by peptide mapping of a low level Tyr to Gln sequence variant in a recombinant antibody. Biotechnology (N Y) 1993;11(11):1293-1297.
9. Besman MJ, Shiba D: Evaluation of genetic stability of recombinant human factor VIII by peptide mapping and on-line mass spectrometric analysis. Pharm Res 1997;14(8):1092-1098.
10. Hu S, Dovichi NJ: Capillary electrophoresis for the analysis of biopolymers. Anal Chem 2002;74(12):2833-2850.
11. Ma S, Nashabeh W: Analysis of protein therapeutics by capillary electrophoresis. Chromatographia 2001;53:S75-S89.
12. Fang X, Tragas C, Wu J, Mao Q, Pawliszyn J: Recent developments in capillary isoelectric focusing with whole-column imaging detection. Electrophoresis 1998;19(13):2290-2295.
13. Lu W, Han DS, Yuan J, Andrieu JM: Multi-target PCR analysis by capillary electrophoresis and laser-induced fluorescence. Nature 1994;368(6468):269-271.
14. Chen FT, Dobashi TS, Evangelista RA: Quantitative analysis of sugar constituents of glycoproteins by capillary electrophoresis. Glycobiology 1998;8(11):1045-1052.
15. Ma S, Nashabeh W: Carbohydrate analysis of a chimeric recombinant monoclonal antibody by capillary electrophoresis with laser-induced fluorescence detection. Anal Chem.1999;71(22):5185-5192.
16. Raju TS, Briggs JB, Borge SM, Jones AJ: Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 2000;10(5):477-486.
17. Lee TT, Yeung ES: High-sensitivity laser-induced fluorescence detection of native proteins in capillary electrophoresis. J Chromatogr 1992;595(1-2):319-325.
18. Colyer C: Noncovalent labeling of proteins in capillary electrophoresis with laser-induced fluorescence detection. Cell Biochem Biophys 2000;33(3):323-337.
19. Lin YW, Chiu TC, Chang HT: Laser-induced fluorescence technique for DNA and proteins separated by capillary electrophoresis. J Chromatogr B 2003;793(1):37-48.
20. Jefferis R: Glycosylation of human IgG antibodies: relevance to therapeutic applications. Biopharm 2001;14:19-26.
21. Schmelzer AE, Miller WM: Hyperosmotic stress and elevated pCO2 alter monoclonal antibody charge distribution and monosaccharide content. Biotechnol Prog 2002;18(2):346-353.
22. Rudd PM, Dwek RA: Rapid, sensitive sequencing of oligosaccharides from glycoproteins. Curr Opin Biotechnol 1997;8(4):488-497.
23. Harvey DJ: Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates and glycoconjugates. Int J Mass Spec 2003;226:1-35.
24. Lopez Garcia F, Zahn R, Riek R, Wuthrich K: NMR structure of the bovine prion protein. Proc Natl Acad Sci U S A 2000;97(15):8334-8339.
25. Watson E, Bhide A, van Halbeek H: Structure determination of the intact major sialylated oligosaccharide chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. Glycobiology 1994;4(2):227-237.
26. Jacobsen NE, Fairbrother WJ, Kensil CR, Lim A, Wheeler DA, Powell MF: Structure of the saponin adjuvant QS-21 and its base-catalyzed isomerization product by 1H and natural abundance 13C NMR spectroscopy. Carbohydr Res 1996;280(1):1-14.
27. Delmas C, Gilleron M, Brando T, Vercellone A, Gheorghui M, Riviere M, Puzo G: Comparative structural study of the mannosylated-lipoarabinomannans from Mycobacterium bovis BCG vaccine strains: characterization and localization of succinates. Glycobiology 1997;7(6):811-817.
28. Clore GM, Gronenborn AM: NMR structure determination of proteins and protein complexes larger than 20 kDa. Curr Opin Chem Biol 1998;2(5):564-570.
29. Kelly SM, Price NC: The use of circular dichroism in the investigation of protein structure and function. Curr Protein Pept Sci 2000;1(4):349-384.
30. Laue TM, Stafford WF III: Modern applications of analytical ultracentrifugation. Annu Rev Biophys Biomol Struct 199928:75-100.
31. Lebowitz J, Lewis MS, Schuck P: Modern analytical ultracentrifugation in protein science: a tutorial review. Protein Sci 2002;11(9):2067-2079.
32. Philo JS: A method for directly fitting the time derivative of sedimentation velocity data and an alternative algorithm for calculating sedimentation coefficient distribution functions. Anal Biochem.2000;279(2):151- 163.
33. Schuck P, Perugini MA, Gonzales NR, Howlett GJ, Schubert D: Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems. Biophys J 2002;82(2):1096-1111.
34. Locksley RM, Killeen N, Lenardo MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001;104(4):487-501.
35. Thomas GJ Jr: Raman spectroscopy of protein and nucleic acid assemblies. Annu Rev Biophys Biomol Struct 1999;28:1-27.
36. Niaura G, Reipa V, Mayhew MP, Holden M, Vilker VL: Structural alterations of the heme environment of cytochrome P450cam and the Y96F mutant as deduced by resonance Raman spectroscopy. Arch Biochem Biophys 2003;409(1):102-112.
37. Krishnamurthy R, Manning MC: The stability factor: importance in formulation development. Curr Pharm Biotechnol.2002 ;(4):361-371.
38. Braun A, Kwee L, Labow MA, Alsenz J: Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice. Pharm Res 1997;14(10):1472-1478.
39. Arai H, Koizumi H, Aoki J, Inoue K: Platelet-activating factor acetylhydrolase (PAF-AH). J Biochem (Tokyo) 2002;131(5):635-640.
40. Wyatt PJ (1993) Light scattering and the absolute characterization of macromolecules. Anal. Chim. Acta 272(1):1-40.
41. Bohidar HB: Light scattering and viscosity study of heat aggregation of insulin. Biopolymers 1998;45(1):1-8.
42. Avanzi GC, Brizzi MF, Giannotti J, Ciarletta A, Yang YC, Pegoraro L, Clark SC: M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J Cell Physiol 1990;145(3):458-464.
43. Meager A, Leung H, Woolley J: Assays for tumour necrosis factor and related cytokines. J Immunol Methods 1989;116(1):1-17.
44. Sadick MD, Intintoli A, Quarmby V, McCoy A, Canova-Davis E, Ling V: Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays. J Pharm Biomed Anal 1999;19(6):883-891.
45. Cook EB, Stahl JL, Lowe L, Chen R, Morgan E, Wilson J, Varro R, Chan A, Graziano FM, Barney NP: Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergies vs. non-allergies. J Immunol Methods 2001;254(1-2):109-118.
46. Spiro A, Lowe M, Brown D: A bead-based method for multiplexed identification and quantitation of DNA sequences using flow cytometry. Appl Environ Microbiol 2000;66(10):4258-4265.
47. Johnson LR, McCormack SA, Yang CH, Pfeffer SR, Pfeffer LM: EGF induces nuclear translocation of STAT2 without tyrosine phosphorylation in intestinal epithelial cells. Am J Physiol 1999;276(2):C419-C425.
48. Burrone OR, Kefford RF, Gilmore D, Milstein C: Stimulation of HLA-A,B,C by IFN-alpha. The derivation of Molt 4 variants and the differential expression of HLA-A,B,C subsets. EMBO J 1985;4(11):2855-2860.
49. Musco ML, Cui S, Small D, Nodelman M, Sugarman B, Grace M: Comparison of flow cytometry and laser scanning cytometry for the intracellular evaluation of adenoviral infectivity and p53 protein expression in gene therapy. Cytometry 1998;33(3):290-296.
50. Zhu J, Musco ML, Grace MJ: Three-color flow cytometry analysis of tricistronic expression of eBFP, eGFP, and eYFP using EMCV-IRES linkages. Cytometry 1999;37(1):51-59.
51. Grace MJ, Xie L, Musco ML, Cui S, Gurnani M, DiGiacomo R, Chang A, Indelicato S, Syed J, Johnson R, Nielsen LL: The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies. Am J Pathol 1999;155(6):1869-1878.
52. Chackerian B, Lenz P, Lowy DR, Schiller JT: Determinants of autoantibody induction by conjugated papillomavirus virus-like particles. J Immunol 2002;169(11):6120-6126.
53. Koren E, Zuckerman LA, Mire-Sluis AR: Immune responses to therapeutic proteins in humans-clinical significance, assessment and prediction. Curr Pharm Biotechnol 2002;3(4):349-360.
54. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S: Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002;20:621-667.
55. Li J, Yang C, Xia Y, Bertino A, Glaspy J, Roberts M, Kuter DJ: Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 2001;98(12):3241-3248.
56. Wadhwa M, Bird C, Dilger P, Gaines-Das R, Thorpe R: Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals. J Immunol Methods 2003;278(1-2):1-17.
57. Takacs MA, Jacobs SJ, Bordens RM, Swanson SJ: Detection and characterization of antibodies to PEG-IFN-alpha2b using surface plasmon resonance. J Interferon Cytokine Res 1999;19(7):781-789.
58. Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian JJ, Martin-Dupont P, Michaud P, Papo T, Ugo V, Teyssandier I, Varet B, Mayeux P: Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002;346(7):469-475.
59. Lucas C, Peterson ML, Bennett GL, Frie SW, Berman PW, Chen AB: A sensitive radioimmunoprecipitation assay for the detection and quantitation of antibodies to the envelope glycoprotein gp120 of the human immunodeficiency virus (HIV-1). AIDS Res Hum Retroviruses 1990;6(3):357-370.
60. Rich RL, Myszka DG: Advances in surface plasmon resonance biosensor analysis. Curr Opin Biotechnol 2000;11(1):54-61.
61. Wierda D, Smith HW, Zwickl CM: Immunogenicity of biopharmaceuticals in laboratory animals. Toxicology 2001;158(1-2):71-74.
62. Wright A, Morrison SL Effect of glycosylation on antibody function: implications for genetic engineering. Trends Biotechnol 1997;15(1):26-32.
63. Routier FH, Hounsell EF, Rudd PM, Takahashi N, Bond A, Hay FC, Alavi A, Axford JS, Jefferis R Quantitation of the oligosaccharides of human serum IgG from patients with rheumatoid arthritis: a critical evaluation of different methods. J Immunol Methods 1998;213(2):113-130.
64. Boyd PN, Lines AC, Patel AK: The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H. Mol Immunol 1995;32(17-18):1311-1318.
65. Wright A, Morrison SL: Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. J Immunol 1998;160(7):3393-3402.
66. Idusogie EE, Presta LG, Gazzano-Santoro H, Totpal K, Wong PY, Ultsch M, Meng YG, Mulkerrin MG: Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J Immunol 2000;164(8):4178-4184.
67. Shields RL, Lai J, Keck R, O'Connell LY, Hong K, Meng YG, Weikert SH, Presta LG: Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 2002;277(30):26733-26740.
68. Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, Hanai N, Shitara K: The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 2003;278(5):3466-3473.
69. Harris RJ: Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture. J Chromatogr A 1995:705(1):129-134.
70. Lam XM, Yang JY, Cleland JL: Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. J Pharm Sci 1997;86(11):1250-1255.
71. Harris RJ, Kabakoff B, Macchi FD, Shen FJ, Kwong M, Andya JD, Shire SJ, Bjork N, Totpal K, Chen AB: Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chromatogr B Biomed Sci Appl 2001;752(2):233-245.
72. Soukharev S, Hammond D, Ananyeva NM, Anderson JA, Hauser CA, Pipe S, Saenko EL: Expression of factor VIII in recombinant and transgenic systems. Blood Cells Mol Dis 2002;28(2):234-248.
73. Reid GE, McLuckey SA: 'Top down' protein characterization via tandem mass spectrometry. J Mass Spectrom 2002;37(7):663-675.
74. White GC II, Beebe A, Nielsen B: Recombinant factor IX. Thromb Haemost 1997;78(1):261-265.
75. Schmidt AE, Bajaj SP: Structure-function relationships in factor IX and factor IXa. Trends Cardiovasc Med 2003;13(1):39-45.
76. Abuchowski A, McCoy JR, Palczuk NC, van Es T, Davis FF: Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem 1977;252(11):3582-3586.
77. Katre NV: Immunogenicity of recombinant IL-2 modified by covalent attachment of polyethylene glycol. J Immunol 1990;144(1):209-213.
78. Bailon P, Palleroni A, Schaffer CA, Spence CL, Fung WJ, Porter JE, Ehrlich GK, Pan W, Xu ZX, Modi MW, Fand A, Berthold W, Graves M: Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C. Bioconjug Chem 2001;12(2):195-202.
79. Chapman AP: PEGylated antibodies and antibody fragments for improved therapy: a review. Adv Drug Deliv Rev 2002;54(4):531-545.
80. Zhang W, Czupryn MJ: Analysis of isoaspartate in a recombinant monoclonal antibody and its charge isoforms. J Pharm Biomed Anal 2003;30(5):1479-1490.